January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Amaro Therapeutics, Inc.
Amaro Therapeutics is building the preeminent biotechnology company around medicine’s first ‘therapeutic’ targets – extra-oral bitter taste receptors – to develop therapies for the treatment of metabolic and immunologic diseases and conditions.